Big Pharma Farms Out Drug Safety to India
Sean Mclain posts in Wall Street Journal Blog about the growing trend of MNC Pharmaceutical companies outsourcing the drug safety monitoring activity.
It is one of outsourcing’s newest frontiers, and the now $2 billion business is booming as regulators require closer tracking of rare side effects and interactions between medicines.
Accenture and other big names in outsourcing, from Tata Consultancy Services Ltd. to Cognizant Technology Solutions Corp. , are getting business from some of the world’s largest drug companies, including AstraZeneca PLC, Novartis AG and Bristol-Myers Squibb Co.
Growing opportunities for pharmacy students in India.
For more information, please visit: http://blogs.wsj.com/indiarealtime/2015/02/02/big-pharma-farms-out-drug-safety-to-india/
It is one of outsourcing’s newest frontiers, and the now $2 billion business is booming as regulators require closer tracking of rare side effects and interactions between medicines.
Accenture and other big names in outsourcing, from Tata Consultancy Services Ltd. to Cognizant Technology Solutions Corp. , are getting business from some of the world’s largest drug companies, including AstraZeneca PLC, Novartis AG and Bristol-Myers Squibb Co.
Growing opportunities for pharmacy students in India.
For more information, please visit: http://blogs.wsj.com/indiarealtime/2015/02/02/big-pharma-farms-out-drug-safety-to-india/
Comments
Post a Comment